Correlation Between Pfizer and ProShares Russell

Can any of the company-specific risk be diversified away by investing in both Pfizer and ProShares Russell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ProShares Russell into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and ProShares Russell 2000, you can compare the effects of market volatilities on Pfizer and ProShares Russell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ProShares Russell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ProShares Russell.

Diversification Opportunities for Pfizer and ProShares Russell

-0.68

Correlation Coefficient

Pfizer  ProShares Russell

Excellent diversification

The 3 months correlation between Pfizer and ProShares is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ProShares Russell 2000 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProShares Russell 2000 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ProShares Russell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProShares Russell 2000 has no effect on the direction of Pfizer i.e., Pfizer and ProShares Russell go up and down completely randomly.

Pair Corralation between Pfizer and ProShares Russell

Considering the 90-day investment horizon Pfizer Inc is expected to generate 1.29 times more return on investment than ProShares Russell. However, Pfizer is 1.29 times more volatile than ProShares Russell 2000. It trades about 0.06 of its potential returns per unit of risk. ProShares Russell 2000 is currently generating about -0.11 per unit of risk. If you would invest  2,540  in Pfizer Inc on December 2, 2024 and sell it today you would earn a total of  103.00  from holding Pfizer Inc or generate 4.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  ProShares Russell 2000

Pfizer Inc

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

ProShares Russell 2000

Risk-Adjusted Performance

Very Weak

Over the last 90 days ProShares Russell 2000 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Etf's fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the fund sophisticated investors.

Pair Trading with Pfizer and ProShares Russell

The main advantage of trading using opposite Pfizer and ProShares Russell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ProShares Russell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProShares Russell will offset losses from the drop in ProShares Russell's long position.

The idea behind Pfizer Inc and ProShares Russell 2000 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.